Robot-assisted versus laparoscopic pancreatoduodenectomy: a pan-European multicenter propensity-matched study.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
02 Apr 2024
Historique:
received: 30 08 2023
revised: 30 01 2024
accepted: 14 02 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 3 4 2024
Statut: aheadofprint

Résumé

The use of robot-assisted and laparoscopic pancreatoduodenectomy is increasing, yet large adjusted analyses that can be generalized internationally are lacking. This study aimed to compare outcomes after robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy in a pan-European cohort. An international multicenter retrospective study including patients after robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy from 50 centers in 12 European countries (2009-2020). Propensity score matching was performed in a 1:1 ratio. The primary outcome was major morbidity (Clavien-Dindo ≥III). Among 2,082 patients undergoing minimally invasive pancreatoduodenectomy, 1,006 underwent robot-assisted pancreatoduodenectomy and 1,076 laparoscopic pancreatoduodenectomy. After matching 812 versus 812 patients, the rates of major morbidity (31.9% vs 29.6%; P = .347) and 30-day/in-hospital mortality (4.3% vs 4.6%; P = .904) did not differ significantly between robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy, respectively. Robot-assisted pancreatoduodenectomy was associated with a lower conversion rate (6.7% vs 18.0%; P < .001) and higher lymph node retrieval (16 vs 14; P = .003). Laparoscopic pancreatoduodenectomy was associated with shorter operation time (446 minutes versus 400 minutes; P < .001), and lower rates of postoperative pancreatic fistula grade B/C (19.0% vs 11.7%; P < .001), delayed gastric emptying grade B/C (21.4% vs 7.4%; P < .001), and a higher R0-resection rate (73.2% vs 84.4%; P < .001). This European multicenter study found no differences in overall major morbidity and 30-day/in-hospital mortality after robot-assisted pancreatoduodenectomy compared with laparoscopic pancreatoduodenectomy. Further, laparoscopic pancreatoduodenectomy was associated with a lower rate of postoperative pancreatic fistula, delayed gastric emptying, wound infection, shorter length of stay, and a higher R0 resection rate than robot-assisted pancreatoduodenectomy. In contrast, robot-assisted pancreatoduodenectomy was associated with a lower conversion rate and a higher number of retrieved lymph nodes as compared with laparoscopic pancreatoduodenectomy.

Sections du résumé

BACKGROUND BACKGROUND
The use of robot-assisted and laparoscopic pancreatoduodenectomy is increasing, yet large adjusted analyses that can be generalized internationally are lacking. This study aimed to compare outcomes after robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy in a pan-European cohort.
METHODS METHODS
An international multicenter retrospective study including patients after robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy from 50 centers in 12 European countries (2009-2020). Propensity score matching was performed in a 1:1 ratio. The primary outcome was major morbidity (Clavien-Dindo ≥III).
RESULTS RESULTS
Among 2,082 patients undergoing minimally invasive pancreatoduodenectomy, 1,006 underwent robot-assisted pancreatoduodenectomy and 1,076 laparoscopic pancreatoduodenectomy. After matching 812 versus 812 patients, the rates of major morbidity (31.9% vs 29.6%; P = .347) and 30-day/in-hospital mortality (4.3% vs 4.6%; P = .904) did not differ significantly between robot-assisted pancreatoduodenectomy and laparoscopic pancreatoduodenectomy, respectively. Robot-assisted pancreatoduodenectomy was associated with a lower conversion rate (6.7% vs 18.0%; P < .001) and higher lymph node retrieval (16 vs 14; P = .003). Laparoscopic pancreatoduodenectomy was associated with shorter operation time (446 minutes versus 400 minutes; P < .001), and lower rates of postoperative pancreatic fistula grade B/C (19.0% vs 11.7%; P < .001), delayed gastric emptying grade B/C (21.4% vs 7.4%; P < .001), and a higher R0-resection rate (73.2% vs 84.4%; P < .001).
CONCLUSION CONCLUSIONS
This European multicenter study found no differences in overall major morbidity and 30-day/in-hospital mortality after robot-assisted pancreatoduodenectomy compared with laparoscopic pancreatoduodenectomy. Further, laparoscopic pancreatoduodenectomy was associated with a lower rate of postoperative pancreatic fistula, delayed gastric emptying, wound infection, shorter length of stay, and a higher R0 resection rate than robot-assisted pancreatoduodenectomy. In contrast, robot-assisted pancreatoduodenectomy was associated with a lower conversion rate and a higher number of retrieved lymph nodes as compared with laparoscopic pancreatoduodenectomy.

Identifiants

pubmed: 38570225
pii: S0039-6060(24)00078-3
doi: 10.1016/j.surg.2024.02.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Alberto Manzoni (A)
Martina Guerra (M)
Freek Daams (F)
Geert Kazemier (G)
Roman Izrailov (R)
Mikhail Efanov (M)
Niccolò Napoli (N)
Michael Ginesini (M)
Marie Cappelle (M)
Roel Haen (R)
Romain Quetel (R)
Marco Pucci (M)
Wouter Derksen (W)
Jeroen Hagendoorn (J)
Fadhel Samir Ftériche (FS)
Milena Muzzolini (M)
Franky Vansteenkiste (F)
Louisa Bolm (L)
Maike Ten Winkel (MT)
Alessandro Giani (A)
Pietro Calcagno (P)

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Anouk M L H Emmen (AMLH)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy; Amsterdam UMC, location University of Amsterdam, Department of Surgery, the Netherlands; Cancer Center Amsterdam, the Netherlands. Electronic address: http://www.twitter.com/AnoukEmmen.

Maurice J W Zwart (MJW)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, the Netherlands; Cancer Center Amsterdam, the Netherlands. Electronic address: http://www.twitter.com/mauricezwart.

Igor E Khatkov (IE)

Department of Surgery, Moscow Clinical Scientific Center, Russia.

Ugo Boggi (U)

Division of General and Transplant Surgery, University of Pisa, Italy.

Bas Groot Koerkamp (B)

Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Olivier R Busch (OR)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Olivier Saint-Marc (O)

Service de Chirurgie Digestive, Endocrinienne et Thoracique, Center Hospitalier Universitaire Orleans, France.

Safi Dokmak (S)

Department of HPB surgery and liver transplantation, Beaujon Hospital, Clichy, France. University Paris Cité.

I Quintus Molenaar (IQ)

Department of Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center, the Netherlands.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital Kortrijk, Belgium.

Marco Ramera (M)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.

Tobias Keck (T)

Clinic for Surgery, University of Schleswig-Holstein Campus Lübeck, Germany.

Giovanni Ferrari (G)

Department of Oncological and Minimally Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Misha D P Luyer (MDP)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Luca Moraldi (L)

Department of Oncology and Robotic Surgery, Careggi University Hospital, Florence, Italy.

Benedetto Ielpo (B)

Department of Surgery, HPB unit, University Mar Hospital, Parc Salut, Barcelona, Spain.

Uwe Wittel (U)

Department of Surgery, University of Freiburg, Germany.

Francois-Regis Souche (FR)

Department de Chirurgie Digestive (A), Mini-invasive et Oncologigue, Hôspital Saint-Eloi, Montpellier, France.

Thilo Hackert (T)

Dept. of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf, Germany.

Daan Lips (D)

Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands.

Mehmet Fatih Can (MF)

Private HPB Surgery Clinic Sogutozu, Ankara, Turkiye.

Koop Bosscha (K)

Department of Surgery, Jeroen Bosch Ziekenhuis, s-Hertogenbosch, the Netherlands.

Regis Fara (R)

Department of Surgery, Hôpital Européen Marseille, France.

Sebastiaan Festen (S)

Department of Surgery, OLVG, Amsterdam, the Netherlands.

Susan van Dieren (S)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, the Netherlands; Cancer Center Amsterdam, the Netherlands.

Andrea Coratti (A)

Department of Oncology and Robotic Surgery, Careggi University Hospital, Florence, Italy.

Ignace De Hingh (I)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

Michele Mazzola (M)

Department of Oncological and Minimally Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Ulrich Wellner (U)

Clinic for Surgery, University of Schleswig-Holstein Campus Lübeck, Germany.

Celine De Meyere (C)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital Kortrijk, Belgium.

Hjalmar C van Santvoort (HC)

Department of Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center, the Netherlands.

Béatrice Aussilhou (B)

Department of HPB surgery and liver transplantation, Beaujon Hospital, Clichy, France. University Paris Cité.

Abdallah Ibenkhayat (A)

Service de Chirurgie Digestive, Endocrinienne et Thoracique, Center Hospitalier Universitaire Orleans, France.

Roeland F de Wilde (RF)

Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Emanuele F Kauffmann (EF)

Division of General and Transplant Surgery, University of Pisa, Italy.

Pavel Tyutyunnik (P)

Department of Surgery, Moscow Clinical Scientific Center, Russia.

Marc G Besselink (MG)

Amsterdam UMC, location University of Amsterdam, Department of Surgery, the Netherlands; Cancer Center Amsterdam, the Netherlands. Electronic address: m.g.besselink@amsterdamUMC.nl.

Mohammad Abu Hilal (M)

Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy. Electronic address: abuhilal9@gmail.com.

Classifications MeSH